Survival among women with triple receptor-negative breast cancer and brain metastases (Q37293398)

19 August 2017

Survival among women with triple receptor-negative breast cancer and brain metastases (English)

1 reference

triple-negative breast cancer

19 August 2017

0 references

author

Ana Maria Gonzalez-Angulo

11

object named as

A M Gonzalez-Angulo

1 reference

19 August 2017

S Dawood

1

1 reference

19 August 2017

K Broglio

2

1 reference

19 August 2017

F J Esteva

3

1 reference

19 August 2017

W Yang

4

1 reference

19 August 2017

S-W Kau

5

1 reference

19 August 2017

R Islam

6

1 reference

19 August 2017

C Albarracin

7

1 reference

19 August 2017

T K Yu

8

1 reference

19 August 2017

M Green

9

1 reference

19 August 2017

G N Hortobagyi

10

1 reference

19 August 2017

15 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

20

1 reference

19 August 2017

4

1 reference

19 August 2017

621-627

1 reference

Breast cancer subtypes and survival in patients with brain metastases

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

CNS metastases in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Molecular portraits of human breast tumours

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Determinants and prognoses of locoregional and distant progression in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Subtypes of breast cancer show preferential site of relapse

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

The natural history of breast cancer patients with brain metastases

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Immunohistochemical profiles of brain metastases from breast cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Primary breast cancer phenotypes associated with propensity for central nervous system metastases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Central nervous system metastasis from breast carcinoma. Autopsy study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2722369

Defining prognosis for women with breast cancer and CNS metastases by HER2 status

3 September 2018

1 reference

12 December 2020

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.

1 reference

12 December 2020

Estrogen receptor: A prognostic factor in breast cancer

1 reference

12 December 2020

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

1 reference

12 December 2020

Breast cancer: metastatic patterns and their prognosis

1 reference

12 December 2020

Nuclear structure in cancer tissues

1 reference

12 December 2020

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDN682

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19150943

1 reference